Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04147013 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients with CRS

StatusActive, Not Recruiting
PhasePhase 4
Started2020-02-18
View on ClinicalTrials.gov ↗
Record status
This record was last updated October 29, 2024 (before its estimated February 2026 completion). Its status may not reflect the trial's current state.

Amendment history

2024-10-25
Recruiting→Active, Not Recruiting Study Identification, Study Status, Conditions, Contacts/Locations v7
Trial statusRecruiting→Active, Not Recruiting
Primary completion date2025-02→2026-02
Completion date2025-04→2026-07
Study sitesdetails revised at 2 of 2 sites
Study titlerevised
Effect of Celecoxib on Postoperative Analgesia and Disease Severity in AERD Patients Withwith CRS
2023-06-15
Study Status, Contacts/Locations v6
Study sites1→2
2023-03-16
Study Status, Sponsor/Collaborators, Contacts/Locations v5
Primary completion date2023-01→2025-02
Completion date2023-04→2025-04
Collaborators2 entries, revised
University of Western OntarioUniversity, Canada
2022-04-05
Study Status v4
Primary completion date2022-01→2023-01
Completion date2022-04→2023-04
2021-11-02
Study Status, Eligibility v3
Eligibility criteria+171 characters
[...] se of analgesics post-FESS History of opioid/narcotic abuse Known Ischemic Heart Disease Known Mild to moderate congestive heart failure Stomach ulceration or bleeding Known Inflammatory bowel disease Chronic pain or chronic opioid use Known renal or hepatic im [...] l, lisinopril) Diuretics (e.g. furosemide) Lithium Cidofovir Carbamazepine Antidepressants
Show 2 earlier versions
2021-02-17
Study Status v2
Primary completion date2020-12→2022-01
Completion date2021-01→2022-04
2020-02-20
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2020-01→confirmed 2020-02-18
Study sitesdetails revised at 1 of 1 site
2019-10-29
Original filing
This is a proposed randomized prospective study to evaluate both the anti-inflammatory and analgesic effects of a COX-2 inhibitor, celecoxib, in patients with aspirin-exacerbated respiratory disease and Chronic rhinosinusitis following endoscopic sinus surgery. The investigators hypothesize that supplementation with celecoxib can potentially improve surgical outcomes and reduce the postoperative usage of opioid analgesics without an increased risk of bleeding or asthma exacerbation
Trial Details
NCT Number NCT04147013
Lead Sponsor London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborators: Western University, Canada, London Health Sciences Centre
Conditions Chronic Rhinosinusitis with Nasal Polyps, Aspirin-exacerbated Respiratory Disease
Enrollment 44 participants
Start Date 2020-02-18
Primary Completion 2026-02 (estimated)
Study Completion 2026-07 (estimated)
Updated on ClinicalTrials.gov 2024-10-29